Stocks / FTV

Fortive Corporation (FTV) Stock Analysis

Technology · Scientific & Technical Instruments · NYSE

Fortive Corporation (FTV) posted $4.16B in revenue for fiscal 2025 (down 33.3% year over year), at a 12.8% net margin, and has compounded revenue about -2.1%/yr over five years, per its SEC filings.

Data last refreshed August 2, 2026 from SEC filings · how we compute this

Price
$59.21
Market Cap
$17.88B
P/E Ratio
31.33
EPS
$1.89
Sector
Technology
52-Week High
$64.56
52-Week Low
$46.34
Dividend Yield
0.41%

The analyst's take on Fortive Corporation

Fortive Corporation has grown revenue from $5.38B to $4.16B over the last 10 fiscal years, compounding about -2.1% a year. The most recent year was down 33.3%, so growth has cooled from its longer-run pace.

Net margin sits at 12.8%, down 0.6 points year over year on a 63.5% gross margin. It carries about $3.21B of total debt.

At today's valuation the market is pricing in roughly 6.5% annual free-cash-flow growth — versus the -6.4% it actually delivered over the last five years, so the price already assumes a step-up from the recent record.

Synthesised from Fortive Corporation's SEC filings — descriptive, not advice. Ask the analyst your own question →

Fortive Corporation revenue & earnings — last 10 fiscal years

Metric2016201720182019202020212022202320242025
Revenue$5.38B$5.76B$6.45B$4.56B$4.63B$5.25B$5.83B$6.07B$6.23B$4.16B
Gross profit$2.69B$2.92B$2.19B$2.48B$2.61B$3.01B$3.36B$2.48B$2.62B$2.64B
Net income$872.30M$1.04B$2.91B$738.90M$1.61B$608.40M$755.20M$865.80M$832.90M$532.70M
Net margin16.2%18.1%45.2%16.2%34.8%11.6%13.0%14.3%13.4%12.8%

Source: Fortive Corporation SEC filings (10-K). 12 years of history available in the interactive view.

Fortive Corporation: no obvious red flags in the filings

Our deterministic scan of the filed statements — receivables vs sales, earnings vs cash, dilution, leverage and margins — didn't flag anything. Ask about the risks →

What growth is priced into FTV stock?

At today's market cap of $17.88B, Fortive Corporation is priced for free-cash-flow growth of about 6.5% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $978.10M from the FY ending 2025-12-31). For comparison, free cash flow actually grew -6.4%/yr over the last five fiscal years and revenue -2.1%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →

Explore 12 years of Fortive Corporation financials — interactive

Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.

Open the interactive view — free

Or start a 7-day free trial to track FTV in your portfolio →

Fortive Corporation financial history by metric

Compare Fortive Corporation with peers

About Fortive Corporation

Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

Fortive Corporation — frequently asked questions

What is Fortive Corporation's revenue?

Fortive Corporation (FTV) reported revenue of $4.16B for fiscal year 2025, down 33.3% from the prior year, according to its SEC filings.

Is Fortive Corporation profitable?

Yes. FTV earned net income of $532.70M in fiscal 2025, a net margin of 12.8%.

What is FTV's P/E ratio?

Fortive Corporation trades at a price-to-earnings ratio of about 31.3 based on the latest data in our nightly-refreshed cache.

How fast is Fortive Corporation growing?

FTV's revenue grew at roughly -2.1% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.

How much debt does Fortive Corporation have?

As of fiscal year 2025, FTV carried roughly $3.21B in total debt (short- plus long-term borrowings), per its filed balance sheet.

What is Fortive Corporation's gross margin?

FTV's gross margin was 63.5% in fiscal 2025 — gross profit of $2.64B on revenue of $4.16B.

What is Fortive Corporation's market cap?

Fortive Corporation (FTV) has a market capitalization of about $17.88B, based on the latest data in our nightly-refreshed cache.

When does Fortive Corporation's fiscal year end?

FTV's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.

What growth is priced into FTV stock?

At today's market cap of $17.88B, Fortive Corporation is priced for free-cash-flow growth of about 6.5% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $978.10M from the FY ending 2025-12-31). For comparison, free cash flow actually grew -6.4%/yr over the last five fiscal years and revenue -2.1%/yr, computed from its SEC filings.

Where does this data come from?

All figures are computed from Fortive Corporation's official SEC filings (10-K and 10-Q), covering 12 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.

Explore more stocks

Browse all 1,500+ companies → · Screen them by fundamentals → · Check earnings quality → · Check share dilution →